About us
Our experts
Services
Our work
Client Cases
Publications
Insights
Careers
Contact
About us
Our experts
Services
Our work
Client Cases
Publications
Insights
Careers
Contact
Home
Publications
All areas of expertise
Climate, Energy, & Natural Resources
Competition
Defence & Supply Chain Resilience
Dispute Support
Healthcare & Life Sciences
Macro & Finance
Postal & Delivery
State Aid
Tender & Auction Support
TMT & Digital
Transfer Pricing
Valuation
Filter publications:
Healthcare & Life Sciences
Novo Nordisk
The economic impact of the pharmaceutical industry in Europe
Healthcare & Life Sciences
PhRMA
How adopting regulatory data protection can increase medicine availability, innovation, and investment
Healthcare & Life Sciences
Economists Without Borders / Impactly
New tool assesses the impact of initiatives against loneliness
Healthcare & Life Sciences
Takeda
Development of novel therapies
Healthcare & Life Sciences
Takeda
Innovating for people living with a rare disease
Healthcare & Life Sciences
Gilead Sciences, Inc.
The impact of remdesivir in the European Union
Healthcare & Life Sciences
Interfarma and PhRMA
Regulatory data protection for pharmaceuticals
Healthcare & Life Sciences
Abbott Norway
Flash glucose monitoring: The societal net cost of offering flash glucose monitors to people with type 2 diabetes on insulin treatment in Norway
Healthcare & Life Sciences
Danish Association of Parallel Importers of Pharmaceuticals
THE ECONOMIC IMPACT OF PARALLEL IMPORTS OF PHARMACEUTICALS – An assessment of savings in Denmark in 2021
Healthcare & Life Sciences
US Hereditary Angioedema Association (HAEA)
Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema
Healthcare & Life Sciences
The Suppliers of Parallel Imported Medicines in Finland
Savings from parallel import of pharmaceuticals in Finland 2016-2020
Healthcare & Life Sciences
Takeda
The impact of plasma-derived therapies in Europe – 2021 edition
Healthcare & Life Sciences
European Expert Group on Orphan Drug Incentives
Orphan medicine incentives
Healthcare & Life Sciences
Acute Team Odense (Akutteam Odense)
The value of Acute Team Odense – an economic analysis of the value of Acute Team Odense’s activities in citizens’ own homes
Healthcare & Life Sciences
Ministry of Employment and Economic Affairs of Finland
Making markets work in the interest of patients
Healthcare & Life Sciences
Abbott Norway
Economic impact of flash glucose monitoring of diabetes in Norway
1
2
3
4
Show more